Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ventrica Assigns MVP To Team Medtronic; Coalescent Going Solo With U-Clip

This article was originally published in The Gray Sheet

Executive Summary

Ventrica, Inc. says it expects its MVP coronary (distal) anastomotic connector to sell at a premium to aortic (proximal) clips given the device's potential to encourage greater use of "off-pump" bypass procedures

You may also be interested in...



St. Jude Optimistic About Symmetry Despite Slower-Than-Expected Adoption

Demand for St. Jude Medical's Symmetry anastomotic bypass graft system will continue to grow slowly for the foreseeable future, even though the device is associated with a better overall patency rate than traditional sutures, the company predicts

St. Jude Optimistic About Symmetry Despite Slower-Than-Expected Adoption

Demand for St. Jude Medical's Symmetry anastomotic bypass graft system will continue to grow slowly for the foreseeable future, even though the device is associated with a better overall patency rate than traditional sutures, the company predicts

Mini-CABG Preferable Over Stenting For Complex Lesions – NEJM Study

Minimally invasive coronary artery bypass grafting (CABG) surgery is associated with fewer major adverse cardiac events and angina symptoms than stenting, a study in the Aug. 22 New England Journal of Medicine concludes

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel